23 June 2009
Stuttering patients' opinions on the Digital Speech Aid
Joanna RatynskaABCDEFG, Agata SzkielkowskaBC, Renata MarkowskaBC, Marek KurkowskiABDF, Marzena MularzukB, Henryk SkarzynskiAGMed Sci Monit 2009; 15(7): CR355-360 :: ID: 869710
Abstract
Background
The Digital Speech Aid (DSA) is a portable device used to reduce stuttering. It incorporates delayed auditory feedback (DAF) and frequency-shifted auditory feedback (FAF). Due to its small size, the DSA can be used by the stutterer in everyday life.
Material and Method
Three hundred thirty-five stutterers aged 6-64 years were included in the study. A subgroup of 100 stutterers who had used the device for at least six months was asked to fill out a questionnaire of 25 questions about their opinion of the device. The data were analyzed and the factors determining the patients' satisfaction with the device were investigated.
Results
The analysis showed that the patients used the DSA regularly for about 3 hours daily. Most patients applied the device at home; only small number used it at work or at school. Most patients (70%) reported decreased fear of speaking and improved self-confidence during communication when using the device (78%). Eighty-eight percent of the patients described the device as very useful or useful in everyday life. That patients' satisfaction with the device was not related to objective speech improvement but to a subjective feeling of increased self-confidence and decreased fear of speaking.
Conclusions
The DSA is positively judged by patients as an option in stuttering therapy. Its effect can be attributed not only to fluency improvement, but also to increased self-confidence and reduced fear of speaking.
Keywords: Speech Therapy - instrumentation, Questionnaires, Health Surveys, Child, Adolescent, Stuttering - therapy
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952